Related Experiment Video
Updated: Aug 29, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Androgen deprivation therapy mimicking acute coronary syndrome: A case report
Yaniel Castro-Torres1, Alexander Triana-Díaz1, Ángel Alexander Cuellar-Gallardo1
1Servicio de Cardiología, Hospital Universitario Celestino Hernández Robau, Santa Clara, Villa Clara, Cuba.
Insights
Androgen deprivation therapy for prostate cancer can cause rare cardiac side effects. This case report highlights drug-induced QT interval prolongation mimicking acute coronary syndrome.
Area of Science:
- Cardiology
- Oncology
- Pharmacology
Background:
- Androgen deprivation therapy (ADT) is a cornerstone treatment for advanced prostate cancer.
- Cardiac side effects, though uncommon, are a potential concern with ADT.
- Electrocardiogram (ECG) abnormalities, including QT interval prolongation, have been rarely reported.
Observation:
- An 80-year-old male on ADT presented with chest pain and ECG changes suggestive of acute coronary syndrome (ACS).
- Initial cardiac workup, including biomarkers and coronary angiography, was negative for ACS.
- Other potential causes like electrolyte imbalance and structural heart disease were ruled out.
Findings:
- Repolarization abnormalities and QT interval prolongation on ECG were observed.
- These cardiac changes resolved after discontinuation of the androgen deprivation therapy.
- The clinical presentation strongly suggested a drug-induced cardiac event.
Implications:
- ADT should be considered as a potential cause of QT interval prolongation and chest pain in prostate cancer patients.
- This case underscores the importance of a thorough medication review in patients presenting with cardiac symptoms.
- Awareness of rare drug side effects can prevent misdiagnosis and unnecessary invasive procedures.
Abstract:
An 80-year-old man diagnosed with prostate cancer and under treatment with androgen deprivation therapy presented at the emergency room with chest pain, repolarization abnormalities and QT interval prolongation on electrocardiogram. An initial diagnosis of acute coronary syndrome was proposed, but biomarkers and coronary angiography were negative. Hydroelectrolyte balance and echocardiogram were also normal. Some weeks after drug withdrawal, repolarization changes reverted. A rare side effect of these drugs mimicking an acute coronary syndrome was the most probable diagnosis.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations

